
Jiangsu Sanmi Biotechnology
Plant-based new materials and multi-omics research services.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
* | N/A | Series A | |
Total Funding | 000k |
Related Content
Jiangsu Sanmi Biotechnology Co., Ltd. is a company specializing in plant-based new materials and life science services, operating a full-chain model from molecular design and genetic breeding to material production and sales. Founded in 2014 by technical personnel from the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, the company leverages its expertise in bio-reactors and gene-editing to commercialize plant-based new materials. The founder and CEO is Dr. Zhou Wenzhi. The company relocated to Nantong in 2016, drawn by local talent and favorable policies.
Sanmi Bio operates two main business lines: research services and the development of plant-based materials. Its research services provide comprehensive technical solutions for the agricultural and medical fields, covering genomics, proteomics, metabolomics, and specialized analysis of starch and polysaccharides. The company serves universities, hospitals, research institutes, and enterprises. In its materials division, Sanmi Bio uses synthetic biology and gene-editing to create novel, special-purpose starches from crops like cassava, sweet potatoes, and potatoes. These plant-based materials are developed for a wide range of applications, including health foods, biomedicine, biodegradable packaging, adhesives, construction, textiles, and papermaking, aiming to provide alternatives to petroleum-based products.
The company's business model integrates R&D with industrial application. It generates revenue from its high-throughput sequencing and multi-omics technical services, and from the sale of its specialty starch and plant-based material products. Sanmi Bio has established platforms for gene editing, cell engineering, and rapid plant propagation. The firm has received multiple rounds of funding, including an angel round from Zhigeng Fund and a Pre-A round led by a fund under the Nantong City Industry Investment Parent Fund, to expand its R&D and production capabilities.
Keywords: plant-based new materials, specialty starch, multi-omics services, synthetic biology, gene editing, polysaccharide analysis, biodegradable materials, genomics, proteomics, metabolomics, agricultural technology, biomedical materials, sustainable materials, high-throughput sequencing, genetic transformation, cassava breeding, sweet potato breeding, biopolymers, bio-adhesives, research and development